Pharmacological countermeasures for the acute radiation syndrome.

@article{Xiao2009PharmacologicalCF,
  title={Pharmacological countermeasures for the acute radiation syndrome.},
  author={Mang Xiao and Mark H. Whitnall},
  journal={Current molecular pharmacology},
  year={2009},
  volume={2 1},
  pages={122-33}
}
The acute radiation syndrome (ARS) is defined as the signs and symptoms that occur within several months after exposure to ionizing radiation (IR). This syndrome develops after total- or partial-body irradiation at a relatively high dose (above about 1 Gy in humans) and dose rate. Normal tissue injuries induced by IR differ depending on the target organ and cell type. Organs and cells with high sensitivity to radiation include the skin, the hematopoietic system, the gut, the spermatogenic cells… CONTINUE READING